Article Details
Retrieved on: 2025-10-10 17:59:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Obinutuzumab is the first glycosylated type II anti-CD20 monoclonal antibody for the treatment of lymphocytic leukemia and follicular lymphoma. This ...
Article found on: journals.plos.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here